Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) Research & Development (2022 - 2025)

Historic Research & Development for Scilex Holding (SCLX) over the last 4 years, with Q3 2025 value amounting to $3.9 million.

  • Scilex Holding's Research & Development rose 6598.55% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year increase of 4440.41%. This contributed to the annual value of $9.6 million for FY2024, which is 2436.06% down from last year.
  • Per Scilex Holding's latest filing, its Research & Development stood at $3.9 million for Q3 2025, which was up 6598.55% from $6.2 million recorded in Q2 2025.
  • Scilex Holding's 5-year Research & Development high stood at $6.2 million for Q2 2025, and its period low was $1.2 million during Q3 2022.
  • In the last 4 years, Scilex Holding's Research & Development had a median value of $2.6 million in 2022 and averaged $2.9 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 22918.35% in 2023, then plummeted by 4231.34% in 2024.
  • Scilex Holding's Research & Development (Quarter) stood at $2.6 million in 2022, then increased by 5.28% to $2.7 million in 2023, then decreased by 20.26% to $2.2 million in 2024, then skyrocketed by 78.85% to $3.9 million in 2025.
  • Its Research & Development was $3.9 million in Q3 2025, compared to $6.2 million in Q2 2025 and $2.5 million in Q1 2025.